Nutrition 21, Inc.
Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results
Published in Cardiovascular Device Liability Week, May 25th, 2008
For the quarter ended March 31, 2008, the company reported total revenues of $10.8 million compared to $15.8 million in the comparable quarter a year ago. The year-ago quarter included a large one-time sale of Selenomax(R) High Selenium Yeast -- without this sale,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Micrus Endovascular Corporation
Micrus Endovascular Fourth Quarter Revenues Increase 23% - Abdominal Aortic Aneurysm
Data from University of Heidelberg provide new insights into abdominal aortic aneurysm - Abdominal Aortic Aneurysm
New findings from Texas A&M University, Medical Department describe advances in abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Recent findings in abdominal aortic aneurysm described by researchers from Fukuoka University, Medical Department - Abdominal Aortic Aneurysm
Studies conducted at C.C. Hsu et al on abdominal aortic aneurysm recently published - Abdominal Aortic Aneurysm Prevention
Study findings from Emory University broaden understanding of abdominal aortic aneurysm prevention - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
